SMN2 and proximal spinal muscular atrophy: For instance, patient 3 (with two SMN2859C copies) developed the first SMA symptoms at 12 years of age, being classified as type IIIb, whereas patient 7 (with the variant in one of his SMN2 genes) had manifestations at 18 months of life with a clinical diagnosis of type IIIa.